Cellectar Biosciences (CLRB)
NASDAQ:CLRB
Holding CLRB?
Track your performance easily

Cellectar Biosciences (CLRB) Cash flow

1,265 Followers

Cellectar Biosciences Cash Flow

CLRB's free cash flow for Q2 2024 was $-14.16M. For the 2024 fiscal year, CLRB's free cash flow was decreased by $-7.79M and operating cash flow was $-14.14M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -44.63M$ -32.38M$ -25.22M$ -22.57M$ -13.93M$ -11.69M
Investing Cash Flow
$ -309.67K$ -864.04K$ -225.97K$ -141.36K$ -62.35K$ -24.54K
Financing Cash Flow
$ 44.29M$ 22.94M$ 9.61M$ 1.25M$ 60.55M$ 9.02M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 80.62M$ 9.56M$ 19.87M$ 35.55M$ 57.17M$ 10.61M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
----$ 1.58K$ 880.00
Issuance Of Capital Stock
--$ 9.61M$ 34.87K$ 59.72M$ 9.02M
Issuance Of Debt
----$ 184.00K$ 0.00
Repayment Of Debt
----$ 0.00$ -2.21K
Free Cash Flow
$ -44.94M$ -33.24M$ -25.45M$ -22.71M$ -14.00M$ -11.72M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Cellectar Biosciences Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis